2196.HK vs. 1093.HK

Last updated Jun 5, 2026

2196.HK (Shanghai Fosun Pharmaceutical Group Co Ltd) and 1093.HK (CSPC Pharmaceutical Group Ltd) are both stocks. Both are in the Healthcare sector — 2196.HK in Drug Manufacturers - Specialty & Generic, 1093.HK in Drug Manufacturers - General. Over the past 10 years, 2196.HK returned -0.52%/yr vs 2.10%/yr for 1093.HK. A 0.51 correlation means they provide meaningful diversification when combined.

Performance

2196.HK vs. 1093.HK - Performance Comparison

The chart below illustrates the hypothetical performance of a HK$10,000 investment in Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK) and CSPC Pharmaceutical Group Ltd (1093.HK). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, 2196.HK achieves a -16.93% return, which is significantly lower than 1093.HK's -14.12% return. Over the past 10 years, 2196.HK has underperformed 1093.HK with an annualized return of -0.52%, while 1093.HK has yielded a comparatively higher 2.10% annualized return.

2196.HK

• 1D: -1.28%
• 1M: -14.12%
• YTD: -16.93%
• 6M: -24.39%
• 1Y: 1.08%
• 3Y*: -6.13%
• 5Y*: -21.67%
• 10Y*: -0.52%

1093.HK

• 1D: -0.14%
• 1M: -12.14%
• YTD: -14.12%
• 6M: -6.10%
• 1Y: -6.48%
• 3Y*: 5.88%
• 5Y*: -6.90%
• 10Y*: 2.10%

*Multi-year figures are annualized to reflect compound growth (CAGR)

2196.HK vs. 1093.HK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
2196.HK Shanghai Fosun Pharmaceutical Group Co Ltd	-16.93%	41.36%	-15.12%	-30.47%	-25.70%	-6.43%	59.67%	3.71%	-53.58%	114.17%
1093.HK CSPC Pharmaceutical Group Ltd	-14.12%	81.38%	-30.97%	-7.80%	-0.70%	8.57%	-56.88%	65.60%	-28.16%	91.65%

Correlation

The correlation between 2196.HK and 1093.HK is 0.62, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.62
Correlation (3Y) Calculated over the trailing 3-year period	0.66
Correlation (5Y) Calculated over the trailing 5-year period	0.62
Correlation (10Y) Calculated over the trailing 10-year period	0.55
Correlation (All Time) Calculated using the full available price history since Oct 31, 2012	0.51

The correlation between 2196.HK and 1093.HK shifts across timeframes, from 0.51 (all time) to 0.66 (3 years), reflecting how their relationship changes across market environments.

Return for Risk

2196.HK vs. 1093.HK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

2196.HK

2196.HK Risk / Return Rank: 39
2196.HK Sharpe Ratio Rank: 40
2196.HK Sortino Ratio Rank: 37
2196.HK Omega Ratio Rank: 36
2196.HK Calmar Ratio Rank: 41
2196.HK Martin Ratio Rank: 40

1093.HK

1093.HK Risk / Return Rank: 34
1093.HK Sharpe Ratio Rank: 34
1093.HK Sortino Ratio Rank: 33
1093.HK Omega Ratio Rank: 33
1093.HK Calmar Ratio Rank: 34
1093.HK Martin Ratio Rank: 34

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

2196.HK vs. 1093.HK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK) and CSPC Pharmaceutical Group Ltd (1093.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	2196.HK	1093.HK	Difference
Sharpe ratio: Return per unit of total volatility	-0.01	-0.17	+0.16
Sortino ratio: Return per unit of downside risk	0.29	0.12	+0.17
Omega ratio: Gain probability vs. loss probability	1.03	1.01	+0.02
Calmar ratio: Return relative to maximum drawdown	-0.01	-0.23	+0.23
Martin ratio: Return relative to average drawdown	-0.01	-0.43	+0.42
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

2196.HK vs. 1093.HK - Sharpe Ratio Comparison

The current 2196.HK Sharpe Ratio is -0.01, which is higher than the 1093.HK Sharpe Ratio of -0.17. The chart below compares the historical Sharpe Ratios of 2196.HK and 1093.HK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	2196.HK	1093.HK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.01	-0.17	+0.16
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.46	-0.16	-0.31
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.01	0.05	-0.06
Sharpe Ratio (All Time) Calculated using the full available price history	0.11	0.16	-0.05

Drawdowns

2196.HK vs. 1093.HK - Drawdown Comparison

The maximum 2196.HK drawdown since its inception was -84.57%, roughly equal to the maximum 1093.HK drawdown of -80.66%. Use the drawdown chart below to compare losses from any high point for 2196.HK and 1093.HK.

Drawdown Indicators

	2196.HK	1093.HK	Difference
Max Drawdown Largest peak-to-trough decline	-84.57%	-80.66%	-3.91%
Max Drawdown (1Y) Largest decline over 1 year	-43.61%	-38.44%	-5.17%
Max Drawdown (3Y) Largest decline over 3 years	-46.62%	-38.44%	-8.18%
Max Drawdown (5Y) Largest decline over 5 years	-84.57%	-60.67%	-23.90%
Max Drawdown (10Y) Largest decline over 10 years	-84.57%	-80.66%	-3.91%
Current Drawdown Current decline from peak	-77.03%	-66.83%	-10.20%
Average Drawdown Average peak-to-trough decline	-40.71%	-39.78%	-0.93%
Ulcer Index Depth and duration of drawdowns from previous peaks	23.49%	20.57%	+2.92%

Volatility

2196.HK vs. 1093.HK - Volatility Comparison

The current volatility for Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK) is 7.16%, while CSPC Pharmaceutical Group Ltd (1093.HK) has a volatility of 12.68%. This indicates that 2196.HK experiences smaller price fluctuations and is considered to be less risky than 1093.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	2196.HK	1093.HK	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.16%	12.68%	-5.52%
Volatility (6M) Calculated over the trailing 6-month period	21.95%	35.19%	-13.24%
Volatility (1Y) Calculated over the trailing 1-year period	38.65%	52.32%	-13.67%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.87%	44.73%	+3.14%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	46.42%	44.44%	+1.98%

Dividends

2196.HK vs. 1093.HK - Dividend Comparison

2196.HK's dividend yield for the trailing twelve months is around 2.16%, more than 1093.HK's 1.93% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
1093.HK CSPC Pharmaceutical Group Ltd	1.93%	2.85%	6.28%	3.44%	2.44%	2.01%	2.36%	0.50%	0.69%	0.40%	0.69%	0.66%
2196.HK Shanghai Fosun Pharmaceutical Group Co Ltd	2.16%	1.79%	2.13%	2.71%	2.64%	1.51%	1.16%	1.53%	2.00%	0.80%	1.59%	1.58%

Financials

Frequently Asked Questions

Can I hold both 2196.HK and 1093.HK in my portfolio?

2196.HK and 1093.HK have a correlation of 0.62, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.